Table 3

Clinical, immunological and virological outcomes for children on antiretroviral treatment (n = 315)

Baseline

6 months

12 months

24 months

36 months


CD4 count

    < 5 years
(%)a

16

30

32

33

35

IQR

(12–19)

(23–35)

(26–34)

(28–36)

(28–40)

N

84

59

48

39

7

    ≥ 5 years
(%)a

13

25

26

29

29

IQR

(9–17)

(18–29)

(21–32)

(24–34)

(19–33)

N

198

175

117

80

24

    ≥ 5 years
(abs)a

297

550

624

704

616

IQR

(181–405)

(337–747)

(459–840)

(562–866)

(492–865)

N

217

183

120

80

24

Hb (mg/dl)b

11.0

12.1

12.6

12.9

13.7

WAZa

-1.9

-1.6

-1.6

-1.5

-1.5

IQR

(-3.0;-0.9)

(-2.6;-0.8)

(-2.6;-0.7)

(-2.5;-0.6)

(-2.7;-0.6)


Viral load

    Months on ART
a

    < 40 c/ml
c

    < 400 c/ml
c

    < 5000 c/ml
c

(n = 174)

18 (15–23)

127 (73.0%)

144 (82.8%)

151 (86.8%)


a Values are expressed as median (interquartile Range (IQR));

b Values are expressed as median;

c Values are expressed as n (%)

abs: absolute CD4 count (in cells/μL); Hb: hemoglobine; WAZ: Weight-for-age Z-score; ART: antiretroviral treatment

van Griensven et al. BMC Pediatrics 2008 8:39   doi:10.1186/1471-2431-8-39

Open Data